Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ocumension Therapeutics ( (HK:1477) ) just unveiled an update.
Ocumension Therapeutics has announced the composition of its board of directors and the roles of each member, highlighting the leadership structure and committee memberships. This announcement provides clarity on the governance of the company, which is crucial for stakeholders to understand the decision-making framework and oversight within the organization.
The most recent analyst rating on (HK:1477) stock is a Buy with a HK$7.29 price target. To see the full list of analyst forecasts on Ocumension Therapeutics stock, see the HK:1477 Stock Forecast page.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry with a focus on developing and commercializing ophthalmic products.
Average Trading Volume: 7,170,339
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.57B
For a thorough assessment of 1477 stock, go to TipRanks’ Stock Analysis page.